Novavax Inc. research and ratings by Barron's. View NVAX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...

Proven effective for COVID-19, vaccine platform could be key in responding to evolving bird flu strains A developmental ...

Nandita Vijayasimha, Bengaluru Tuesday, April 22, 2025, 08:00 Hrs [IST] ...

A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...

According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

The U.S. is experiencing an outbreak of measles and is on track to have the most whooping cough cases since 1948; these ...

The recent success of an experimental bird flu vaccine in trials marks a significant step forward in the fight against avian influenza. Researchers from the University of Buffalo have demonstrated ...

The adjuvants are mixed into the phospholipid layer. The vaccine is what’s known as a recombinant protein vaccine. Unlike ...